Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg EMA closed 18-22 April 2019 16 april 2019NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2019 12 april 2019NewsHumanPharmacovigilanceReferrals Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing 12 april 2019Press releaseHumanPharmacovigilanceReferrals Update of EU recommendations for 2019/2020 seasonal flu vaccine composition 12 april 2019NewsHumanVaccines The role of regulators in establishing added benefit of novel therapies 11 april 2019NewsHumanCorporateResearch and development EU recommendations for 2019/2020 seasonal flu vaccine composition 1 april 2019NewsHumanVaccines Regulatory information – 1.7% increase of fees from 1 April 2019 1 april 2019NewsCorporateFees Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 March 2019 29 maart 2019NewsHumanData on medicines EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack 29 maart 2019Press releaseHumanReferrals New gene therapy to treat rare inherited blood condition 29 maart 2019Press releaseHumanData on medicines 1 … 105 106 107 108 109 Page 109 of 384 110 111 112 113 … 384
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2019 12 april 2019NewsHumanPharmacovigilanceReferrals
Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing 12 april 2019Press releaseHumanPharmacovigilanceReferrals
Update of EU recommendations for 2019/2020 seasonal flu vaccine composition 12 april 2019NewsHumanVaccines
The role of regulators in establishing added benefit of novel therapies 11 april 2019NewsHumanCorporateResearch and development
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 March 2019 29 maart 2019NewsHumanData on medicines
EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack 29 maart 2019Press releaseHumanReferrals
New gene therapy to treat rare inherited blood condition 29 maart 2019Press releaseHumanData on medicines